Vorinostat Terminated Phase 1 / 2 Trials for Cutaneous Lymphomas / Cutaneous T-Cell Lymphoma (CTCL) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs